An official website of the United States government
NIH Guide: Weekly Index for December 15, 2023
Weekly NIH Funding Opportunities and Notices
December 15, 2023
Policy Notices
-
NIH Operates Under a Continuing Resolution
(NOT-OD-24-039)National Institutes of Health
General Notices
-
Request for Information (RFI): Inviting Comments on the National Institutes of Health (NIH) Strategic Plan for Data Science 2023-2028
(NOT-OD-24-037)Office of the Director, NIH
Notice of Changes to Funding Opportunities
-
Notice of NCI's participation in PAR-23-302, Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
(NOT-CA-24-019)National Cancer Institute
-
Notice of Change to the budget limits in RFA-DA-25-047 and RFA-DA-25-048, "Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 and R43/R44 Clinical Trials Optional)"
(NOT-DA-23-047)National Institute on Drug Abuse
-
Notice of Participation of NIDDK in PAR-23-309 Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
(NOT-DK-24-006)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of NIDDK's Participation in PAR-23-237 -Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed)
(NOT-DK-24-008)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Change to Budget Instructions in PAR-22-180 "Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)"
(NOT-GM-24-012)National Institute of General Medical Sciences
-
Notice of the Discontinuation of NIGMS's Participation in PA-23-271 "Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
(NOT-GM-24-013)National Institute of General Medical Sciences
-
Notice of Change to Institutional Eligibility Criteria in PAR-23-138 "Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)"
(NOT-GM-24-014)National Institute of General Medical Sciences
-
Notice to Clarify Letter of Intent Due Dates for RFA-NR-24-002 "Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed)"
(NOT-NR-24-004)National Institute of Nursing Research
-
Notice of Change: Post-Submission Materials for RFA-NS-24-005 - BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
(NOT-NS-24-042)National Institute of Neurological Disorders and Stroke
-
Notice of Corrections to PAR-24-054 Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
(NOT-TR-24-007)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Sites for the Environmental influences on Child Health Outcomes (ECHO) IDeA States Pediatric Clinical Trials Network- 3 (UG1 Clinical Trial Required)
(NOT-OD-24-045)Office of the Director, NIHNational Institute of General Medical SciencesNational Institute on Drug AbuseEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentOffice of Behavioral and Social Sciences Research
-
Notice of Intent to Publish a Funding Opportunity Announcement for Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - 3 (U24 Clinical Trial OptionalInfrastructure)
(NOT-OD-24-046)Office of the Director, NIHNational Institute of General Medical SciencesNational Institute on Drug AbuseEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentOffice of Behavioral and Social Sciences Research
Notices of Special Interest
-
Notice of Special Interest (NOSI): Quantum Sensing Technologies in Biomedical Applications
(NOT-EB-23-022)National Institute of Biomedical Imaging and BioengineeringNational Institute of General Medical SciencesNational Cancer InstituteNational Eye InstituteNational Heart, Lung, and Blood InstituteNational Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
-
Notice of Special Interest (NOSI): Administrative Supplements to Support Extramural Collaborators for Notified Applicants for the Bench-to-Bedside and Back Program (BtB) (Clinical Trial Optional)
(NOT-OD-24-027)Office of the Director, NIH
-
Notice of Special Interest (NOSI): Research Council of Finland (RCF) National Institutes of Health (NIH) Partnership Program
(NOT-OD-24-040)Office of the Director, NIHNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Eye InstituteNational Institute of Biomedical Imaging and Bioengineering
Funding Opportunities
-
Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional)
(PAR-23-319)John E. Fogarty International CenterNational Institute on AgingNational Cancer InstituteNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeOffice of Disease PreventionApplication Receipt Date(s): March 11, 2024
-
Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)
(PAR-24-055)National Institute of General Medical SciencesApplication Receipt Date(s): Not Applicable
-
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
(PAR-24-072)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
(PAR-24-082)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): March 13, 2024
-
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
(PAR-24-085)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
(PAR-24-088)National Institute of Mental HealthNational Institute on AgingNational Institute on Drug AbuseNational Eye InstituteApplication Receipt Date(s): November 5, 2024
-
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
(PAR-24-091)National Institute on AgingNational Institute on Alcohol Abuse and AlcoholismNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeOffice of Research on Women's HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
(PAR-24-092)National Institute on AgingNational Institute on Alcohol Abuse and AlcoholismNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeOffice of Research on Women's HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)
(RFA-AI-23-065)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): April 29, 2024
-
Bat Immunology Network Research Projects (R01 Clinical Trial Not Allowed)
(RFA-AI-23-068)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): May 24, 2024
-
Bat Immunology Network Research Resource Program (U24 Clinical Trial Not Allowed)
(RFA-AI-23-069)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): May 24, 2024
-
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
(RFA-CA-24-016)National Cancer InstituteApplication Receipt Date(s): November 15, 2024
-
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
(RFA-CA-24-017)National Cancer InstituteApplication Receipt Date(s): November 15, 2024
-
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
(RFA-CA-24-018)National Cancer InstituteApplication Receipt Date(s): November 15, 2024
-
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
(RFA-CA-24-019)National Cancer InstituteApplication Receipt Date(s): November 15, 2024
-
FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
(RFA-FD-24-022)Food and Drug AdministrationApplication Receipt Date(s): February 29, 2024
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster